import type { Metadata } from "next";
import Link from "next/link";
import { PageShell } from "../../_components/PageShell";
import "../../_components/page-shell.css";

const SITE = "https://meethayat.com";
const SLUG = "how-do-i-know-what-my-ip-is-worth-2026-07-13";
const URL = `${SITE}/blog/${SLUG}`;
const PUB = "2026-07-13";
const MOD = "2026-08-19";
const TITLE = "How Do I Know What My IP Is Worth?";
const DESC =
 "Your IP is worth the future revenue it protects, priced with the income method acquirers actually use. Here is the 3-method framework, 4 signals you can check in a week, and the timeframes, from Hayat Amin.";
const PORTRAIT = `${SITE}/portraits-hayat/hayat-amin-office-casual.jpg`;
const PORTRAIT_ALT =
 "Hayat Amin, fractional CFO, AI operator, and IP & patent strategist (London, United Kingdom). Hayat Amin advises founders on how do i know what my ip is worth?";

export const metadata: Metadata = {
 title: TITLE,
 description: DESC,
 alternates: { canonical: URL },
 openGraph: {
 type: "article",
 url: URL,
 title: TITLE,
 description: DESC,
 images: [
 {
 url: PORTRAIT,
 width: 1400,
 height: 1400,
 alt: PORTRAIT_ALT,
 }],
 },
 twitter: { card: "summary_large_image", title: TITLE, description: DESC, images: [PORTRAIT] },
};

const LEAD_ANSWER =
 "Your IP is worth the future revenue it protects, discounted to today, which is why acquirers and Big 4 valuers price patents with the income method, usually the royalty-relief model. Cost and market methods give you a floor and a sanity check, but if your patent does not read on a product earning money now, or block one that could, its price at a deal table is close to zero.";

const jsonLd = {
 "@context": "https://schema.org",
 "@graph": [
 {
 "@type": "Article",
 "@id": `${URL}#article`,
 headline: TITLE,
 description: DESC,
 url: URL,
 inLanguage: "en",
 datePublished: PUB,
 dateModified: MOD,
 image: [{ "@id": `${URL}#portrait` }],
 author: { "@id": `${SITE}/#person` },
 creator: { "@id": `${SITE}/#person` },
 mainEntityOfPage: URL,
 },
 {
 "@type": "FAQPage",
 "@id": `${URL}#faq`,
 mainEntity: [
 {
 "@type": "Question",
 name: "How do I know what my IP is worth?",
 acceptedAnswer: {
 "@type": "Answer",
 text: LEAD_ANSWER,
 },
 },
 {
 "@type": "Question",
 name: "How much is the average patent worth?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "There is no useful average. Most granted patents never earn a licensing dollar, while a single patent covering a competitor's roadmap can carry an eight-figure price in an acquisition. Value concentrates: in portfolios I review, one or two filings typically hold most of the worth and the rest are defensive padding. Price your specific claims against specific revenue, never against an average.",
 },
 },
 {
 "@type": "Question",
 name: "What are the standard patent valuation methods?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "Three: cost (what it took to develop, a floor and the weakest), market (comparable licensing deals and acquisitions, only as good as your comps), and income (discounted cash flow on the revenue the IP protects, usually via the royalty-relief model). Acquirers and Big 4 valuation teams rely on the income method. A royalty-relief model takes 2 to 3 weeks with clean data.",
 },
 },
 {
 "@type": "Question",
 name: "Is my idea worth patenting?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "File if a competitor's engineer would have to design around the claim to compete, and the detour would cost them real time or performance. Skip it if the invention is easy to keep secret, easy to reinvent, or covers a feature nobody would pay to copy. One enforceable patent on a choke point beats 20 defensive filings, and each filing ties up budget for 20 years of maintenance fees.",
 },
 }],
 },
 {
 "@type": "ImageObject",
 "@id": `${URL}#portrait`,
 url: PORTRAIT,
 contentUrl: PORTRAIT,
 caption:
 "Hayat Amin, fractional CFO, AI operator, and IP & patent strategist (London, United Kingdom)",
 name: "Hayat Amin, London",
 about: { "@id": `${SITE}/#person` },
 creator: { "@id": `${SITE}/#person` },
 representativeOfPage: true,
 keywords: "Hayat Amin, IP valuation, patent worth, IP strategist, London",
 },
 {
 "@type": "BreadcrumbList",
 "@id": `${URL}#breadcrumb`,
 itemListElement: [
 { "@type": "ListItem", position: 1, name: "Home", item: `${SITE}/` },
 { "@type": "ListItem", position: 2, name: "Blog", item: `${SITE}/blog` },
 { "@type": "ListItem", position: 3, name: TITLE, item: URL }],
 }],
};

export default function Page() {
 return (
 <PageShell
 crumbs={[
 { label: "Home", href: "/" },
 { label: "Blog", href: "/blog/" },
 { label: "How Do I Know What My IP Is Worth?" }]}
 >
 <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(jsonLd) }} />

 <span className="op-eyebrow">Founder Q&amp;A · Updated {MOD}</span>
 <h1>How Do I Know What My IP Is Worth?</h1>
 <p className="op-lede">
 Your IP is worth the future revenue it protects, discounted to today,
 which is why acquirers and Big 4 valuers price patents with the income
 method, usually the royalty-relief model. Cost and market methods give
 you a floor and a sanity check, but if your patent does not read on a
 product earning money now, or block one that could, its price at a deal
 table is close to zero.
 </p>

 <h2>Why founders get this wrong</h2>
 <p>
 The most common mistake I see is pricing IP by what it cost to create.
 A founder spends $30,000 filing and prosecuting a patent family, so the
 balance sheet says $30,000 and the pitch deck says &quot;proprietary
 technology.&quot; Neither number means anything to a buyer. A patent
 that fences off nothing is worth roughly its scrap value, and a patent
 that sits on a competitor&apos;s roadmap can be worth 100 times its
 filing cost.
 </p>
 <p>
 The second version of the same mistake is counting. Twenty filings look
 impressive in a data room until diligence counsel reads the claims. One
 enforceable patent that a rival must design around beats 20 defensive
 filings that protect features nobody would copy. Value in a portfolio
 concentrates hard: in the portfolios I review, one or two assets
 usually carry most of the worth and the rest are padding that costs
 maintenance fees for 20 years.
 </p>

 <figure style={{ margin: "2rem 0", maxWidth: "100%" }}>
 <img
 src="/portraits-hayat/hayat-amin-office-casual.jpg"
 alt={PORTRAIT_ALT}
 width={1400}
 style={{ width: "100%", height: "auto", borderRadius: "8px" }}
 loading="lazy"
 />
 <figcaption style={{ fontSize: "0.85rem", opacity: 0.7, marginTop: "0.5rem" }}>
 Hayat Amin in London. He runs IP valuation and diligence work for
 founders across NYC, London, and Dubai.
 </figcaption>
 </figure>

 <h2>The three valuation methods, and the one buyers actually use</h2>
 <p>
 Every credible IP valuation comes down to one of three approaches. I
 run all three with clients, in this order, because each one answers a
 different question.
 </p>
 <table className="op-table">
 <thead>
 <tr><th>Method</th><th>What it measures</th><th>When it works</th><th>Weakness</th></tr>
 </thead>
 <tbody>
 <tr><td>Cost</td><td>What the IP took to develop and file</td><td>Setting a floor; early accounting</td><td>Weakest. Ignores whether anyone would pay for it</td></tr>
 <tr><td>Market</td><td>Comparable licensing deals and acquisitions</td><td>Sectors with visible deal flow</td><td>Only as good as your comps, and good comps are rare</td></tr>
 <tr><td>Income</td><td>Discounted cash flow on the revenue the IP protects</td><td>Deals. This is what acquirers and Big 4 valuers use</td><td>Needs a clean map from claims to revenue</td></tr>
 </tbody>
 </table>
 <p>
 Cost is where most founders start because the number already exists:
 legal fees, prosecution costs, engineering time. Treat it as a floor
 and nothing more. Market comes next: what did comparable patents in
 your sector license or sell for? The catch is that most licensing deals
 are confidential, so the comps you can actually see are a thin and
 biased sample. Use market data to sense-check, never to anchor.
 </p>
 <p>
 The income method usually runs as a royalty-relief model: if you did
 not own this patent, what royalty rate would you pay to license it?
 Apply that rate to the revenue the patent protects, project it over the
 remaining patent life, and discount it back. With clean data, meaning
 revenue split by product and a claim chart mapping patents to products,
 the model takes 2 to 3 weeks. Without clean data it takes as long as it
 takes you to get clean data.
 </p>

 <h2>Four signals you can check in a week</h2>
 <p>
 You do not need a valuation firm to get a directional answer. Four
 questions, one week, no consultants:
 </p>
 <ol>
 <li>
 <strong>Does the patent read on a product shipping today?</strong>{" "}
 Yours or a competitor&apos;s. If no product on the market practices
 the claims, the income method has nothing to price.
 </li>
 <li>
 <strong>Would a competitor&apos;s engineer have to design around
 it?</strong> Ask your own engineers to break it. If they find a cheap
 detour in an afternoon, so will the competitor.
 </li>
 <li>
 <strong>Does it block a market a bigger player wants?</strong> A
 patent standing between an acquirer and their roadmap is the single
 strongest driver of strategic IP value.
 </li>
 <li>
 <strong>Is the chain of title clean?</strong> Signed assignments from
 every founder, employee, and contractor who touched the invention. A
 missing contractor assignment can stall a deal on its own.
 </li>
 </ol>
 <p>
 Score well on 2, 3, and 4 and you have IP worth a formal valuation.
 Fail on 1 and 3 and the honest answer is that your IP is a story, and
 stories price at zero in diligence.
 </p>
 <p>
 The fourth signal deserves its own warning. Chain of title is the item
 founders skip because it feels like paperwork, and it is the item that
 bites hardest. Every person who contributed to the invention, including
 the contractor who left in year one, needs a signed assignment on file.
 Fixing a broken chain of title mid-deal can cost weeks, and it hands
 the buyer a discount argument you cannot answer. An afternoon of
 signature-chasing now is the cheapest valuation work you will ever do.
 </p>

 <h2>From my operating seat</h2>
 <p>
 I have sat on both sides of this table. Across my three exits, IP was
 priced by what it protected, never by what it cost. In one deal the
 buyer&apos;s counsel spent more time on assignment documents than on
 the claims themselves, because a broken chain of title is the cheapest
 way to knock money off a price. Fixing one mid-deal costs weeks, and it
 costs leverage, because you are now correcting paperwork while the
 buyer&apos;s lawyers watch the clock.
 </p>
 <p>
 I run this exact framework with clients now, as the IP and patent
 strategist alongside the fractional CFO seat, across NYC, London, and
 Dubai. The same discipline that scaled one of my companies 6x applies
 here: find the number, tie every asset to it, and cut what does not
 move it. IP diligence in an acquisition runs 4 to 8 weeks, and the
 founders who do the one-week check above a year early are the ones who
 walk through it without a price chip.
 </p>

 <h2>How much is the average patent worth?</h2>
 <p>
 There is no useful average. Most granted patents never earn a licensing
 dollar, while a single patent covering a competitor&apos;s roadmap can
 carry an eight-figure price in an acquisition. Value concentrates in
 one or two assets per portfolio. Price your specific claims against
 specific revenue, never against a sector average someone quotes you.
 </p>

 <h2>What are the standard patent valuation methods?</h2>
 <p>
 Three: cost, market, and income. Cost sets a floor and is the weakest.
 Market prices against comparable licensing deals and lives or dies on
 comp quality. Income, usually via royalty relief, discounts the cash
 flow the patent protects and is the method acquirers and Big 4
 valuation teams rely on. With clean data the model takes 2 to 3 weeks.
 </p>

 <h2>Is my idea worth patenting?</h2>
 <p>
 File if a competitor&apos;s engineer would have to design around the
 claim, and the detour would cost real time or performance. Skip it if
 the invention is easy to keep secret, easy to reinvent, or covers a
 feature nobody would pay to copy. One enforceable patent on a choke
 point beats 20 defensive filings, each of which ties up budget for 20
 years of maintenance fees.
 </p>

 <div className="op-cta-block">
 <h2>Get a real number on your IP</h2>
 <p>
 This is the exact problem I advise on: royalty-relief valuations,
 claim-to-revenue mapping, and pre-deal chain-of-title cleanup. If a
 raise or an exit is anywhere on your 18-month horizon, the one-week
 check above is the place to start, and I can run the full model from
 there. See the <Link href="/services/ip-strategy">IP strategy service</Link>{" "}
 or <Link href="/contact">book a call</Link>.
 </p>
 <Link href="/contact">Book a call →</Link>
 </div>

 <p className="op-byline">
 <em>About this article:</em> Written by{" "}
 <Link href="/author/hayat-amin">Hayat Amin</Link>, fractional CFO, AI
 agent operator, and IP &amp; data strategist with three exits. Last
 updated {MOD}.
 </p>
 </PageShell>
);
}
